Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Adeojo LW"'
Autor:
Adeojo LW; Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California San Francisco, San Francisco, CA 94143-0912, USA., Patel RC; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA., Sambol NC; Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California San Francisco, San Francisco, CA 94143-0912, USA.
Publikováno v:
Pharmaceutics [Pharmaceutics] 2024 Aug 07; Vol. 16 (8). Date of Electronic Publication: 2024 Aug 07.
Autor:
Nasser A; Supernus Pharmaceuticals, Inc., Rockville, Maryland., Randall Owen J; Navitor Pharmaceuticals, Inc., Boston, Massachusetts., Gomeni R; Pharmacometrica, Lieu-dit Longcol, La Fouillade, France., Kosheleff AR; Supernus Pharmaceuticals, Inc., Rockville, Maryland., Portelli J; Supernus Pharmaceuticals, Inc., Rockville, Maryland., Adeojo LW; Supernus Pharmaceuticals, Inc., Rockville, Maryland., Hughes TE; Navitor Pharmaceuticals, Inc., Boston, Massachusetts. Electronic address: thughes@navitorpharma.com.
Publikováno v:
Clinical therapeutics [Clin Ther] 2024 Mar; Vol. 46 (3), pp. 217-227. Date of Electronic Publication: 2024 Mar 13.
Autor:
Wang Z; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, USA., Kosheleff AR; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, USA., Adeojo LW; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, USA., Odebo O; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, USA., Liranso T; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, USA., Schwabe S; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, USA., Nasser A; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, USA. anasser@supernus.com.
Publikováno v:
European journal of drug metabolism and pharmacokinetics [Eur J Drug Metab Pharmacokinet] 2022 Jan; Vol. 47 (1), pp. 69-79. Date of Electronic Publication: 2021 Oct 15.
Autor:
Nasser A; Supernus Pharmaceuticals Inc., Rockville, Maryland, USA., Gomeni R; Pharmacometrica, Lieu-dit Longcol, La Fouillade, France., Wang Z; Supernus Pharmaceuticals Inc., Rockville, Maryland, USA., Kosheleff AR; Supernus Pharmaceuticals Inc., Rockville, Maryland, USA., Xie L; Supernus Pharmaceuticals Inc., Rockville, Maryland, USA., Adeojo LW; Supernus Pharmaceuticals Inc., Rockville, Maryland, USA., Schwabe S; Supernus Pharmaceuticals Inc., Rockville, Maryland, USA.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2021 Dec; Vol. 61 (12), pp. 1626-1637. Date of Electronic Publication: 2021 Aug 08.
Autor:
Wang Z; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Kosheleff AR; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Adeojo LW; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Odebo O; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Adewole T; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Qin P; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Maletic V; Department of Psychiatry/Behavioral Science, University of South Carolina School of Medicine, Greenville, South Carolina, USA., Schwabe S; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Nasser A; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA.
Publikováno v:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2021 Nov; Vol. 10 (11), pp. 1365-1374. Date of Electronic Publication: 2021 May 04.
Autor:
Cushion MT; Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.; Cincinnati Veterans Affairs Medical Center, Cincinnati, Ohio, USA., Kumar P; Clinical Pharmacokinetics Research Unit, Pharmacy Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA., Lu R; Matinas BioPharma Inc, Bedminster, New Jersey, USA., Ashbaugh A; Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Adeojo LW; Clinical Pharmacokinetics Research Unit, Pharmacy Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA., Alfaro R; Clinical Pharmacokinetics Research Unit, Pharmacy Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA., Mannino R; Matinas BioPharma Inc, Bedminster, New Jersey, USA., Tramont E; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Kovacs JA; Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2021 Jul 15; Vol. 224 (2), pp. 326-331.
Autor:
Kim H; Juvenile Myositis Pathogenesis and Therapeutics Unit, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA hanna.kim@nih.gov.; Pediatric Clinical Trials Unit, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Dill S; Pediatric Clinical Trials Unit, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.; Office of the Clinical Director, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., O'Brien M; Pediatric Clinical Trials Unit, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.; Office of the Clinical Director, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Vian L; Translational Immunology Section, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Li X; Biostatistics and Clinical Epidemiology Service, National Institutes of Health Clinical Center, Bethesda, Maryland, USA., Manukyan M; Pediatric Clinical Trials Unit, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.; Office of the Clinical Director, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Jain M; Rehabilitation Medicine Department, Physical Therapy Section, National Institutes of Health Clinical Center, Bethesda, Maryland, USA., Adeojo LW; Clinical Pharmacokinetics Research Unit, Pharmacy Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA., George J; Clinical Pharmacokinetics Research Unit, Pharmacy Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA., Perez M; Pediatric Rheumatology, Cook Children's Medical Center, Fort Worth, Texas, USA., Grom AA; Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Sutter M; Department of Rheumatology, Children's Hospital Colorado, Aurora, Colorado, USA.; Pediatrics Rheumatology, University of Colorado Denver, Denver, Colorado, USA., Feldman BM; Division of Rheumatology, Hospital for Sick Children, Toronto, Ontario, Canada.; Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada., Yao L; Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, Maryland, USA., Millwood M; Pediatric Clinical Trials Unit, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.; Office of the Clinical Director, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Brundidge A; Pediatric Clinical Trials Unit, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.; Office of the Clinical Director, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Pichard DC; Dermatology Branch, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Cowen EW; Dermatology Branch, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Shi Y; Office of the Clinical Director, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Lu S; Translational Immunology Section, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Tsai WL; Translational Immunology Section, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Gadina M; Translational Immunology Section, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Rider LG; Environmental Autoimmunity Group, NIEHS/NIH/DHHS, Bethesda, Maryland, USA., Colbert RA; Pediatric Clinical Trials Unit, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.; Office of the Clinical Director, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.
Publikováno v:
Annals of the rheumatic diseases [Ann Rheum Dis] 2021 Mar; Vol. 80 (3), pp. 406-408. Date of Electronic Publication: 2020 Aug 25.
Autor:
Park LT; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD., Kadriu B; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD., Gould TD; Veterans Affairs Maryland Health Care System, Baltimore, MD.; Departments of Psychiatry, Pharmacology, Anatomy & Neurobiology and Physiology, University of Maryland School of Medicine, Baltimore, MD., Zanos P; Departments of Psychiatry, Pharmacology, Anatomy & Neurobiology and Physiology, University of Maryland School of Medicine, Baltimore, MD., Greenstein D; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD., Evans JW; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD., Yuan P; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD., Farmer CA; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD., Oppenheimer M; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD., George JM; Clinical Pharmacokinetics Research Unit, Pharmacy Department, National Institutes of Health, Bethesda, MD., Adeojo LW; Clinical Pharmacokinetics Research Unit, Pharmacy Department, National Institutes of Health, Bethesda, MD., Snodgrass HR; VistaGen Therapeutics, Inc., San Francisco, CA., Smith MA; VistaGen Therapeutics, Inc., San Francisco, CA.; Medical College of Georgia, Augusta, GA., Henter ID; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD., Machado-Vieira R; Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Science Center, Houston, TX., Mannes AJ; Clinical Center, Department of Perioperative Medicine, National Institutes of Health, Bethesda, MD., Zarate CA; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD.
Publikováno v:
The international journal of neuropsychopharmacology [Int J Neuropsychopharmacol] 2020 Jul 29; Vol. 23 (7), pp. 417-425.
Autor:
Shrager, Joseph B., Randle, Ryan, Myung Lee, Ahmed, Syed Saadan, Trope, Winston, Natalie Lui, Poultsides, George, Doug Liou, Visser, Brendan, Norton, Jeffrey A., Nesbit, Shannon M., Hao He, Kapula, Ntemena, Wallen, Bailey, Fatodu, Emmanuel, Sadeghi, Cheyenne A., Konsker, Harrison B., Elliott, Irmina, Guenthart, Brandon, Backhus, Leah
Publikováno v:
Life Science Alliance; Nov2024, Vol. 7 Issue 11, p1-14, 14p
Publikováno v:
Expert Review of Neurotherapeutics; May2024, Vol. 24 Issue 5, p443-455, 13p